Pathos

Pathos is a United States-based biotechnology company headquartered in Chicago, Illinois. The company employs 77 people and generates over $10,000 in annual revenue. Pathos focuses on developing clinical-stage therapeutics for cancer patients. They achieve this by licensing or co-developing drugs tailored to specific patient pathways, aiming to provide highly effective treatments for those with significant unmet needs. Their patient selection strategies prioritize rapid approval processes to deliver improved patient outcomes as quickly as possible. Pathos distinguishes itself through its unique approach to cancer treatment. They believe cancer is comprised of numerous rare diseases, each requiring targeted therapies. By focusing on specific pathways involved in cancer development, Pathos seeks to accelerate the translation of real-world data into breakthrough therapies. Visit Pathos online at pathos.com.